Ligand Pharm (LGND)
$102.80
2.21 (2.10%)
LGND Stock Quote Delayed 30 Minutes
LGND Stock Earnings: Ligand Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024
LGND stock results show that Ligand Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
1.71B
PE Ratio
44.50
EPS
2.31
Volume (Avg. Vol.)
384,755
Day's Range
$102.77 - $105.23
52-Week Range
$49.24 - $112.13
Dividend & Yield
N/A (N/A)
LGND Stock Predictions, Articles, and Ligand Pharm News
Redditors Are Betting on a $600 Ligand Stock Short Squeeze
LGND stock is now the most-shorted stock available to Robinhood traders. Here's why investors should tread lightly going forward.
Best ETFs for 2018: Don’t Sweat This Quarter for the SBIO ETF
On a year-to-date basis, SBIO still looks good, up 14.30%, or 310 basis points better than the Nasdaq Biotechnology Index. Year-to-date, SBIO is also outpacing the equal-weight S&P Biotechnology Select Industry Index.
5 Biotech Stocks to Boost Your Portfolio’s Health This Year
Though the biotech industry is down this year, there are still a few stocks which can strengthen your portfolio. Compare Brokers....
24 Biotechnology Stocks to Sell Now
This week, the ratings of 24 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Biggest Movers in Manufacturing Stocks Now – KTOV JUNO CCXI CARA
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
4 Biotechnology Stocks to Buy Now
The grades of 4 Biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
